Evidence map›Paper›PMID 41487930›Full record

ArticleCancer diagnosis & prognosis

C-reactive Protein-to-Albumin Ratio as a Superior Inflammatory Marker in Resected Biliary Tract Cancer: Development of a Prognostic Nomogram Complementary to TNM Staging.

Shinichi Ikuta, Tsukasa Aihara, Takayoshi Nakajima, Masataka Fujikawa, Naoki Yamanaka

Abstract read
In one paragraph

Article in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shinichi IkutaDepartment of Surgery, Meiwa Hospital, Hyogo, Japan.
Tsukasa AiharaDepartment of Surgery, Meiwa Hospital, Hyogo, Japan.
Takayoshi NakajimaDepartment of Surgery, Meiwa Hospital, Hyogo, Japan.
Masataka FujikawaDepartment of Surgery, Meiwa Hospital, Hyogo, Japan.
Naoki YamanakaDepartment of Surgery, Meiwa Hospital, Hyogo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Aim: Consensus on the most informative inflammatory marker for prognosis in biliary tract cancer (BTC) is lacking. The aim of this study was to comprehensively evaluate preoperative inflammatory indices and develop a prognostic nomogram complementary to TNM staging. Patients and Methods: A total of 247 patients with resected BTC were retrospectively analyzed. Eight inflammatory indices, including prognostic nutritional index (PNI) and C-reactive protein-to-albumin ratio (CAR), were assessed alongside non-TNM clinicopathological variables. Least absolute shrinkage and selection operator (LASSO) regression identified overall survival-associated variables for multivariable Cox regression and nomogram construction. Model performance was evaluated using Kaplan-Meier analysis, concordance (C-) index, time-dependent area under the curve (tdAUC), decision curve analysis (DCA), and calibration plots, with bootstrap validation. Results: LASSO selected PNI and CAR; CAR remained independently significant. The nomogram incorporated CAR and five clinicopathological factors: body mass index ≥25 kg/m2, carbohydrate antigen 19-9 >37 U/ml, moderate/poor differentiation, perineural invasion, and residual tumor status. Patients were stratified by nomogram score into four risk groups showing distinct survival differences. Notably, 50.6% of TNM Stage I-II were reclassified as higher risk, 16.1% of Stage III-IV as lower risk. The nomogram achieved C-index 0.722 Conclusion: CAR demonstrated superiority over other inflammatory indices in resected BTC. This CAR-based nomogram complements TNM staging, offering enhanced prognostic stratification for patients with heterogeneous outcomes within the same anatomical stage.

Indexed as

Biliary tract cancerC-reactive protein-to-albumin ratioinflammatory indicesprognostic nomogramTNM staging

Identifiers

PMID41487930
PMCPMC12758671

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.